An agent that activates natural killer cells and is useful in renal cell carcinoma is:
**Core Concept**
The question is testing the student's knowledge of immunotherapy and its application in cancer treatment. The underlying concept is the activation of natural killer cells, a type of lymphocyte that plays a key role in the innate immune response against cancer cells.
**Why the Correct Answer is Right**
The correct answer is Interferon-alpha (IFN-α). IFN-α is a cytokine that activates natural killer cells and has been shown to be effective in the treatment of renal cell carcinoma (RCC). It works by binding to the IFN-alpha receptor on the surface of immune cells, including natural killer cells, which leads to the activation of these cells and their ability to recognize and kill cancer cells. This is an example of immunotherapy, which is a type of cancer treatment that harnesses the power of the immune system to fight cancer.
**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because Interleukin-2 (IL-2) is another cytokine that activates natural killer cells, but it is not the most commonly used agent in the treatment of renal cell carcinoma.
* **Option B:** This option is incorrect because Interferon-gamma (IFN-γ) is a cytokine that activates macrophages and T cells, but it is not the primary agent used to activate natural killer cells in the treatment of renal cell carcinoma.
* **Option D:** This option is incorrect because Interleukin-12 (IL-12) is a cytokine that activates T cells and natural killer cells, but it is not the most commonly used agent in the treatment of renal cell carcinoma.
**Clinical Pearl / High-Yield Fact**
A key point to remember is that interferons, including IFN-α, have a broad range of antitumor effects, including the induction of apoptosis in cancer cells, inhibition of angiogenesis, and enhancement of the immune response against cancer cells.
**Correct Answer:** C. Interferon-alpha (IFN-α)